Skip to main content

Industry News

Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.

Algonquin College Opens Centre for Construction Excellence

Published 11/26/2011

Algonquin College opened the $79 million Centre for Construction Excellence in Ottawa in November of 2011. Designed by Diamond + Schmitt Architects in collaboration with Edward J. Cuhaci and Associates, the 190,000-sf facility provides classrooms, studios, laboratories, and shops. The project is designed to function as a teaching laboratory for sustainable construction and comprises a five-story tower and a two-story wing.

Read More

Yeshiva University's Einstein College of Medicine Opens Cognitive Neurophysiology Lab

Published 11/26/2011

Yeshiva University's Einstein College of Medicine opened the Cognitive Neurophysiology Laboratory in New York in November of 2011. The mission of the Cognitive Neurophysiology Lab is to understand how the brain function of individuals with disorders such as autism, attention deficit disorder, and childhood schizophrenia differs from that of their peers. The facility includes a new 5,000-sf lab with specialized rooms that allow researchers to control sound and other stimuli.

Read More

Joint School of Nanoscience and Nanoengineering Opens in Greensboro

Published 11/25/2011

The Joint School of Nanoscience & Nanoengineering (JSNN) opened in Greensboro, N.C., in November of 2011. The $64 million project was created collaboratively by North Carolina A&T State University and the University of North Carolina at Greensboro. The facility was built by a joint venture of Samet Corp., Barton Mallow, and SRS Inc.

Read More

Novavax Expands in Gaithersburg

Published 11/24/2011

Novavax is expanding its operations in Gaithersburg, Md., with the long-term lease of 74,000 sf of manufacturing, lab, and office space in two buildings. The main facility will undergo renovation to become Novavax's primary commercial-scale plant for cGMP production of seasonal and pandemic VLP influenza vaccines. Completion is expected in mid-2012. The company's corporate headquarters will be relocated to the second building at the same campus.

Read More